Home » Joshua Bumgarner

Joshua Bumgarner

Joshua Bumgarner

LinkedIn

Education:

B.A. in Chemistry from Willamette University, Salem OR, 2017

From: Walla Walla WA

Joined David Lab: April 2018

Outside of lab: I like to go on hikes or spend time with my big goofy labradoodle. I’m also a big foodie who loves to try new restaurants and drinks

Research in David Lab:

BER glycosylases are usually highly specific in the type of damage they repair, and when they repair it. The NEIL family of glycosylases are unusual in their ability to work on a multitude of different DNA lesions, and can often do so in DNA contexts outside of canonical B-DNA. I work to understand what dictates when a NEIL enzyme repairs a lesion, and what influences when it when it does not. I have used a variety of different lesions to develop structure activity relationships between specific bases to better learn what structures of the base are required for recognition and repair, what which impair NEIL activity. In addition, most enzymatic assays are performed in dilute buffer systems, however this is not necessarily the case in a cell. The impact of the crowded environment of a cell, known as macromolecular crowding, can significantly impact enzymatic activity. I have been working to incorporate this into our enzyme assays and understand how it changes our understanding of the enzymes behavior between a test tube and the cellular environment.

Previous Research Experience:

I previously studied macromolecular crowding under Dr. Todd Silverstein at Willamette university, working to understand the influence of crowding agents on the pH profile of alcohol dehydrogenase, and how it altered the construction and pKa’s of the active site. I have also worked at the Hawaii Institute of Marine Biology studying the ability of coral to acclimate to increasing water temperatures over the past 40 years, and the inventible climb in ocean temperatures in the years to come.

RSS Science Daily News

  • 'Dancing molecules' heal cartilage damage July 26, 2024
    New therapy uses synthetic nanofibers to mimic the natural signaling of a protein that is crucial for cartilage formation and maintenance. Researchers found that intensifying the motion of molecules within the nanofibers led to more components needed for regeneration. After just four hours, the treatment activated the gene expression necessary to generate cartilage. Therapy could […]
  • New understanding of fly behavior has potential application in robotics, public safety July 26, 2024
    Scientists have identified an automatic behavior in flies that helps them assess wind conditions -- its presence and direction -- before deploying a strategy to follow a scent to its source. The fact that they can do this is surprising -- can you tell if there's a gentle breeze if you stick your head out […]
  • Lampreys possess a 'jaw-dropping' evolutionary origin July 26, 2024
    Lampreys are one of only two living jawless vertebrates Jaws are formed by a key stem cell population called the neural crest New research reveals the gene regulatory changes that may explain morphological differences between jawed and jawless vertebrates.
  • Researchers develop state-of-the-art device to make artificial intelligence more energy efficient July 26, 2024
    Engineering researchers have demonstrated a state-of-the-art hardware device that could reduce energy consumption for artificial intelligent (AI) computing applications by a factor of at least 1,000.
  • New drug shows promise in clearing HIV from brain July 25, 2024
    An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment.

Contact:

Dr. Sheila S. David
ssdavid@ucdavis.edu
(530)-752-4280

Department of Chemistry
One Shields Ave.
Davis, CA 95616